05.06.2013 To the attention of interested persons NAMMD press release on market withdrawal, at wholesale distributor level, of CILEST 0.250mg/0.035mg, […]

05.06.2013 To the attention of interested persons The NAMMD, in cooperation with ARPIM and APMGR announce the “Quality of the […]

05.06.2013 To the attention of interested persons Press release of the National Agency for Medicines and Medical Devices on the […]

07.05.2013 To the attention of Marketing Authorisation Holders As regards medicinal products submitted for marketing authorisation renewal through national procedure, […]

05.03.2013 To the attention of Marketing Authorisation Holders Submission of the pharmacovigilance system summary for medicinal products undergoing marketing authorisation […]

29.01.2013 To the attention of interested persons In January 2013, THE NATIONAL AGENCY FOR MEDICINES AND MEDICAL DEVICES (NAMMD) and […]

23.01.2013 Attention of Marketing Authorisation Holders The National Agency for Medicines and Medical Devices hereby reminds you the 2 dedicated […]

04.01.2013 To the attention of Marketing Authorisation Holders The National Agency for Medicines and Medical Devices hereby reiterates the availabilityy […]

25.10.2012 To the attention of Marketing Authorisation Holders concerning trimetadizine-containing medicinal products The NAMMD hereby emphasises the mandatory character of […]